Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
| Autor: | Raghini Ranganathan, Krishnaveni Janarthanan, Senthilkumar Rajasekaran |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Type 1 diabetes
Hepatology Combination therapy Diabetic ketoacidosis business.industry Hepatitis C virus Ribavirin virus diseases Case Report medicine.disease medicine.disease_cause digestive system diseases chemistry.chemical_compound chemistry Pegylated interferon Interferon Immunology medicine business medicine.drug Pegylated Interferon Alfa |
| Zdroj: | Journal of Clinical and Experimental Hepatology. 2:86-87 |
| ISSN: | 0973-6883 |
| DOI: | 10.1016/s0973-6883(12)60089-9 |
| Popis: | A 16-year-old female was treated with pegylated-interferon (PEG-IFN) alfa (a)-2b and ribavirin combination therapy for chronic hepatitis C virus (HCV) infection. She attained rapid virological response. She presented with diabetic ketoacidosis after 41 weeks of therapy. Anti-glutamic acid decarboxylase antibodies and islet cell antibodies were negative. Her fasting serum C-peptide level was |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect